North America Drug Delivery Systems Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country

No. of Pages: 249    |    Report Code: TIPRE00005752    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Drug Delivery Systems Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Drug Delivery Systems Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Drug Delivery Systems Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing demand for targeted drug delivery systems
  • 5.1.2 Advancements in drug delivery technologies for chronic diseases
5.2 Market Opportunities
  • 5.2.1 Advancements in drug delivery technologies creating opportunities for targeted and efficient drug delivery systems
  • 5.2.2 Rising demand for personalized drug delivery driving market growth
5.3 Future Trends
  • 5.3.1 Demand for non-invasive drug delivery systems
  • 5.3.2 Advancements in controlled-release and personalized drug delivery solutions
5.4 Impact of Drivers and Restraints

6. North America Drug Delivery Systems Market Regional Analysis

6.1 North America Drug Delivery Systems Market Overview
6.2 North America Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)
6.3 North America Drug Delivery Systems Market Forecast Analysis

7. North America Drug Delivery Systems Market Analysis – by Route of Administration

7.1 Transmucosal
  • 7.1.1 Overview
  • 7.1.2 Transmucosal: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Oral
  • 7.2.1 Overview
  • 7.2.2 Oral: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Injectable
  • 7.3.1 Overview
  • 7.3.2 Injectable: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Topical
  • 7.4.1 Overview
  • 7.4.2 Topical: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Implantable
  • 7.5.1 Overview
  • 7.5.2 Implantable: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Ocular
  • 7.6.1 Overview
  • 7.6.2 Ocular: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Drug Delivery Systems Market Analysis – by Distribution Channel

8.1 Hospital Pharmacies
  • 8.1.1 Overview
  • 8.1.2 Hospital Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Retail Pharmacies
  • 8.2.1 Overview
  • 8.2.2 Retail Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Pharmacies
  • 8.3.1 Overview
  • 8.3.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Drug Delivery Systems Market Analysis – by Application

9.1 Home Care Settings
  • 9.1.1 Overview
  • 9.1.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospitals & Clinics
  • 9.2.1 Overview
  • 9.2.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Drug Delivery Systems Market – North America Analysis

10.1 North America
  • 10.1.1 North America Drug Delivery Systems Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 10.1.1.1 North America Drug Delivery Systems Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.1.2 US: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.1.3 US: North America Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.2.2 Canada: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.2.3 Canada: North America Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.3.2 Mexico : North America Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.3.3 Mexico : North America Drug Delivery Systems Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Drug Delivery Systems Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Novo Nordisk A/S
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 3M
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Boston Scientific Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Bausch Health Companies Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Baxter International, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Boehringer Ingelheim
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Novartis AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Johnson & Johnson Services, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

The List of Companies - North America Drug Delivery Systems Market

1. BD
2. Novo Nordisk A/S
3. 3M
4. Boston Scientific Corporation
5. Bausch Health Companies Inc.
6. Baxter International, Inc.
7. Boehringer Ingelheim
8. Novartis AG
9. GlaxoSmithKline plc.
10. Johnson & Johnson Services, Inc.